cellvie AG
- Biotech or pharma, therapeutic R&D
cellvie is developing mitochondria as a new treatment modality, pioneering in manufacturing, storage and therapeutic uses. The first indication shall be in ischemia-reperfusion injury, with gene therapy delivery as a first pipeline application.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}